Archive for dubai

No plea bargains this Presidents’ Day

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , on February 18, 2009 by David Granovsky

“Look no further than the bungled response to Katrina, the children left behind by No Child Left Behind, the vetoes of SCHIP (expanding health care for 6-10 million children) and the stem cell research bill.”

presidentsday

presidentsday

No plea bargains this Presidents’ Day

Sunday, February 15, 2009 1:47 AM EST -By GORDON GLANTZ

Tomorrow we have Presidents’ Day — systematically stationed between the birthdays of George Washington and Abraham Lincoln — to ostensibly honor the efforts and service of all our presidents.

What, then, do we do with the batch of terrible leaders we have endured in our history?

Presidents like the one who just packed up his duds and headed for Texas.

Some of you are now gnashing your teeth, saying: “He’s really going there again?”

Well, you better just move on to the comics or check out your horoscope.

I’m going there again.

And you can’t tell me that the eve of this rather minor holiday isn’t the perfect time to embark on such an excursion. Like Martin Luther King Jr. Day being a day of service instead of a day of sales, this is when presidential legacies — real and conjured — should be placed under the microscope.

Once nightmarish presidents decide to perish from the earth, rose-colored glasses are donned. There is a state funeral and every talking head with a microphone, blockhead blogger with a laptop or working stiff on a bar stool accentuates the positives — whatever few there may be — and lets the negatives blur and fade.
The textbooks tend to be just as kind — and inaccurate.

Because He Whose Name Shall Not Be Written (or spoken) is alive and kickin’ back, we must now act with haste.

While it hasn’t been a month, the view from here ain’t looking too good.

New president Barack Obama is finding out just what he got himself into. He will be spending perhaps all of his first term cleaning up his yo-yo of a predecessor’s mess.

Because the economy is such an overwhelming concern, the issues that loomed the largest during the marathon campaign season — health care, the ill-conceived war that virtually pushed the economy down this slippery slope, immigration, the environment, education, special interests, etc. — are placed out of view like gardening tools in a backyard shed during winter.

One would have to go to a nuthouse or a board meeting of one of the Big Three to find a potential president who could have created more problems in more areas in less than a decade of fumbling and bumbling.

For you people who wonder why I won’t even utter his name — why I wouldn’t consider him to have been my president — look no further than his pitiful body of work.

Look no further than the bungled response to Katrina, the children left behind by No Child Left Behind, the vetoes of SCHIP (expanding health care for 6-10 million children) and the stem cell research bill.

Look no further than opposition to the Kyoto Protocol, which is an international fight on greenhouse admissions that won’t discriminate between those who believe in the end of days and those who don’t.

Heck, this guy managed to anger his own conservative base with his “temporary worker program.”

Even a broken clock is right twice a day — but not when you want to sell port security to a Dubai-based company. Not when you want to appoint a glorified secretary, Harriet Miers, to the U.S. Supreme Court.

Weapons of mass destruction, anyone? Civil war in Iraq — fought on the graves of more than 4,000 American soldiers? Mission accomplished?

Scandals? You want scandals? Scooter Libby? Alberto Gonzales?

And Osama bin Laden, the mastermind of Sept. 11, is still doing his broadcasts.

Want to be horrified? Read former press secretary Scott McClellan’s tell-all book, “What Happened.” Mortified? Listen and learn from what other former aides and staffers are now coming out of hiding and revealing.

The ex-president’s public defenders, while trying to plead him down to misdemeanor offenses, will offer up Sept. 11 in the court of public opinion.

I’ll give you part of that. Without that unforgettable day, we would have been looking at a run-of the-mill president whom nobody took too seriously — especially because he didn’t really win the 2000 election — who tried to peddle a redundant conservative agenda before getting voted out of office after one term (just like his daddy did).

But it happened, that unforgettable day. Like those great presidents for whom tomorrow is designed, he was handed the weight of a major crisis and gift-wrapped a chance for greatness.

He had a chance to unite this country of cliques and, through poor decision after poor decision, left it more charred with schisms.

He responded to the challenges by looking like Woody Allen trying to bench press his own weight. In turn, his approval rating between Sept. 11 of 2001 and his last day sullying the Oval Office dipped from 90 to 20 percent.

Let it go, you say? I understand your intention, but riddle me this: How are we to move forward without looking back and fully understanding how one president can let so much unravel on his watch?

There should be no pleading his case to misdemeanor charges in the court of public opinion. He has too much blood — foreign and domestic — on his hands. He is a felon.

Republicans, even those who soured on this clown long ago, say that history will wrap him in redemption.

Welcome to Cop Out City, folks. This is the place where we speak in code — like “history will be more kind … blah, blah, blah” — in order to close the door on what they see as a belabored conversation and, more importantly, avoid the harsh reality.

But each of us — of all political proclivities and walks of life — are living this harsh reality every day.

Including Presidents’ Day.

via No plea bargains this Presidents’ Day – The Times Herald Opinion > Columnists: Norristown, PA and Montgomery County (timesherald.com).

Stem Cells: Politics, processes and potential : Neapolitan : Naples Daily News

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , , , , , on February 18, 2009 by David Granovsky
science-ethics-politics

science-ethics-politics

Stem Cells: Politics, processes and potential

BETH KALVIN, Director of Communications/Regenocyte Therapeutic -6:00 p.m., Monday, February 16, 2009

After the inauguration of President Barack Obama, those on both sides of the stem cell research debate are expecting President Bush’s curb on federal funding to be lifted.

Geron Corp. announced it had received approval from the U.S. Food and Drug Administration for the world’s first study of a human embryonic stem cell therapy, testing its product on patients with acute spinal cord injury. The company reported it has spent “at least $100 million on embryonic stem cell research” and it isn’t alone in its quest.

So while the majority of public and private dollars are poured into embryonic stem cell research, advocates of other stem cell therapies are lobbying for a share, with strong clinical results behind them. The chasm between types of stem cells is nearly as wide as the divergence of opinion on the political and ethical issues. The impacts of a legislative change may depend heavily on the current administration’s — and the public’s — understanding of the science that is now becoming medicine.

Embryonic stem cells can develop into any cell of the body, and scientists have long hoped to harness them for creating replacement tissues to treat a variety of diseases. But to date no successful human treatment has been found using embryonic cells. The treatment research has been controversial because human embryos must be destroyed. Plus, the pluripotent quality of the cells poses many risks for adverse effects.

Cord blood cells, when saved or “banked,” can address many serious diseases and are considered much safer than embryonic cells because they are autologous, meaning cells belonging to the patient, and the body will not reject its own cells. However, the availability of cord blood cells is limited and tissue matching is required.

Adult stem cells circulate throughout our bodies and act as natural healers. They have vast potential and limitless capabilities. As a treatment option, they are considered extremely safe because they are also autologous, coming directly from the patient’s own blood, bone marrow, skin or fat. For more than 40 years, adult stem cells have been used to treat cancers, particularly leukemia.

Recent advancements in adult stem cell therapy have meant thousands of patients around the world have been helped for serious health conditions outside of cancer. The process begins with drawing of the patient’s blood or marrow. The stem cells are then extracted in a biotechnology lab.

Bio-agents like growth factors are applied to expand the stem cell population and direct the cells to repair and regenerate specific tissue damaged by disease.

Just a few days later, the newly engineered cells are reintroduced to the patient’s body by injection or through a catheter into the blood vessels. The patient generally returns home in one to two days and the regeneration process within their body begins.

Southwest Florida-based Regenocyte Therapeutic released data last month to the World Congress on Regenerative Biomedical Technologies on patients treated for heart, vascular and pulmonary diseases that were studied through one year after Adult Stem Cell Therapy. The report showed measurable improvement in congestive heart failure class status, breathing and kidney function. PET scans confirmed that adult stem cells have the ability to engraft themselves into areas damaged by heart attacks and turn into viable, new heart muscle.

Dr. Héctor José Rosario, professor of cardiology at Pontifical Catholic University School of Medicine and director of cardiovascular therapy for Regenocyte’s Dominican division, stated in the report that “three months after treatment, cardiac nuclear scans of the areas treated reveal reversal of damage.” The company’s medical adviser, Athina Kyritsis, M.D., explains: “Regenocyte has been able to take patients off the transplant list, and we have been doing it consistently.”

Dr. Kyritsis explains the potential to revolutionize medicine is great: “I believe we have only begun to discover what adult stem cells can accomplish in altering the course of diseases currently believed to be untreatable, with not only better clinical results than embryonic cell studies offer, but a long-term financial savings to society.”

Regenocyte Therapeutic is using adult stem cell therapy to treat congestive heart failure, cardiomyopathy, peripheral artery disease, coronary artery disease, kidney disease, ischemic heart disease, pulmonary diseases and hypertension, and early senile dementia. The U.S. Clinical Center with complete diagnostic capabilities and its own catheterization lab is located in Bonita Springs, where there are 39 employees and associates. Physicians, treatment and laboratory facilities are also located in Israel and the Dominican Republic.

An educational seminar, “Turning Stem Cells into Medicine: Current Clinical Applications and Case Studies,’’ will be held Saturday, March 7, at 1 p.m. at the Collier Regional Library headquarters on Orange Blossom Drive in North Naples. The program is free and open to the public, featuring Zannos G. Grekos, MD, who is director of Cardiology & Vascular Disease for Regenocyte Therapeutic. Dr. Grekos also is associate clinical professor of cardiology for Nova Southeastern University. In 2007, he was invited to brief the U.S. Senate Health Advisory Committee on the current state of stem cell research and has since lectured at international physician conferences from Washington to Dubai, U.A.E.

via Stem Cells: Politics, processes and potential : Neapolitan : Naples Daily News.